# Endomaster Pte

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/endomaster-pte

- Industry: Medical Devices & Equipment
- Headquarters: Singapore, Singapore
- Website: www.endomastermedical.com
- Total disclosed funding: $13M
- Latest round: Series B (Sep 17, 2018)
- Investors on record: 3

## About

Endomaster Pte Ltd is a Singapore-based company specializing in innovative medical technology, focusing on the development of advanced endoscopic solutions and minimally invasive surgical instruments to enhance surgical precision.Founded in 2011 in Singapore, Endomaster Pte Ltd develops advanced endoscopic technology. The company has completed a total of 3 deals, with its most recent funding round being a Series B in September 2018, raising USD 12.77 mn from investors including Hoya Corporation and NTUitive. Currently, it is valued at USD 31.05 mn.Endomaster Medical specializes in advanced medical technology, primarily focused on developing innovative endoscopic solutions and minimally invasive surgical instruments. Their core offerings include a range of specialized endoscopes designed to enhance visualization and precision during surgical procedures. These products aim to address critical challenges in the medical field, such as reducing patient recovery times and improving surgical outcomes. The company targets a diverse client base that includes hospitals, surgical centers, and healthcare providers across various geographical markets, particularly focusing on North America, Europe, and parts of Asia. Endomaster Medical’s products are engineered to meet the needs of skilled surgeons and procedural specialists who require effective tools for complex surgeries.Endomaster Medical generates revenue through direct sales of its endoscopic devices to hospitals and healthcare providers, establishing partnerships for broader access to its technology. In the most recent year of 2018, the company reported a revenue of USD 0, while its EBITDA in 2021 was USD -4,185,902.80.Following the Series B funding round in September 2018, which raised USD 12.77 mn, Endomaster Pte Ltd plans to utilize this capital to accelerate the development of new endoscopic products aimed at enhancing surgical outcomes and increasing market penetration. The company is targeting expansion into North America and Europe by 2021, with the goal of establishing a stronger presence in these critical markets.

## Funding rounds

- Series B, Sep 17, 2018, $13M — Hoya Corporation, NTUitive, Sino-Singapore Suzhou Industrial Park Industrial Investment

## Investors

- Hoya Corporation — Series B
- NTUitive (https://capitalatlas.ai/funds/ntuitive) — Series B
- Sino-Singapore Suzhou Industrial Park Industrial Investment — Series B